Author: admin
Integral Molecular Launches Virus Neutralization Assay Services to Drive Antiviral Discovery
Researchers can now access Integral Molecular’s antibody testing expertise alongside its extensive collection of virus-like reagents including reporter viruses, VLPs, and pseudoviruses to acquire […]
Webinar Presented by Integral Molecular and The Antibody Society – Harnessing Divergent Species to Access Difficult and Conserved Antibody Targets
Thursday, April 25, 2024 8 am PT, 11 am ET, 17:00 CET View the recording To exploit highly conserved and difficult drug targets, including […]
Integral Molecular Achieves ISO 9001 Certification for its Membrane Proteome Array Service
ISO 9001 certification validates Integral Molecular’s quality processes for its Membrane Proteome Array, reflecting the company’s commitment to quality. Philadelphia – Integral Molecular, a […]
Integral Molecular Launches TiterSafe™ Influenza Virus-Like Particles for Safe and Convenient Vaccine Testing
Philadelphia – Integral Molecular, a leading provider of reagents for vaccine evaluation, announces the launch of TiterSafe™ influenza virus-like particles, an off-the-shelf virus-alternative for […]
Integral Molecular Unveils Trispecific Molecules Targeting GPRC5D, BCMA, and CD3 for Multiple Myeloma
Philadelphia – Integral Molecular, a leading biotech company specializing in antibody discovery against undruggable protein targets will present multispecific molecules targeting GPRC5D, BCMA, and […]
Integral Molecular Secures Nearly $900K in NIH Funding to Discover Antibodies Against Difficult and Conserved Protein Targets
PHILADELPHIA–Integral Molecular, a leading biotech company specializing in antibody discovery against challenging protein targets, announces that it has been awarded NIH funding totaling $896,000. […]